APUS - Apimeds Pharmaceuticals US, Inc. | Scanr.ai
APUS
Apimeds Pharmaceuticals US, Inc.
Manufacturing
|
Pharmaceutical Products
|
XASE
5.75
-2.25
-28.13%
Jul 29, 3:59 PM EDT
Enlarge chart
Fullscreen chart
O 8.1H 7.97L 5.155C 5.4Vol 235.39K
Jul 29, 2026
Apimeds Pharmaceuticals US, Inc.
We are a clinical stage biopharmaceutical company that is in the process of developing Apitox,an intradermally administered bee venom-based toxin which potentially exhibits diverse therapeutic effects. We are located at 2 East Broad Street, 2nd Floor, Hopewell, New Jersey.
